Cargando…
No damos consejo médico — la decisión es tuya y de tu médico.
A new drug called suzetrigine offers relief from acute pain without the risks of opioids, such as addiction or respiratory depression. Studies in postoperative patients show it is as effective as traditional painkillers.
Pain after surgery is common and often treated with opioids, which can cause addiction and other side effects. Suzetrigine is an innovative drug that blocks a specific sodium channel (NaV1.8) involved in pain transmission, without affecting the central nervous system like opioids.
In clinical trials with patients undergoing bunionectomy and abdominoplasty, suzetrigine significantly reduced postoperative pain compared to placebo, and its efficacy was comparable to the combination of hydrocodone and acetaminophen. The most common side effects were mild gastrointestinal symptoms.
This drug represents a promising alternative for acute pain management, especially in the context of the opioid crisis. However, more research is needed to evaluate its long-term safety and use in chronic pain.
If you are planning to undergo plastic surgery, ask your surgeon about options for postoperative pain management. Is suzetrigine available in their practice? What alternatives to opioids do they offer to minimize the risk of addiction?
This content summarizes scientific publications and professional-society guidelines; it does not replace your surgeon's or anesthesiologist's evaluation. Every item links its original source.